Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · IEX Real-Time Price · USD
17.81 -0.35 (-1.93%)
Jan 21, 2022 4:00 PM EST - Market closed

Balance Sheet (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year20202019
Cash & Equivalents
17.4132.47
Cash & Cash Equivalents
17.4132.47
Cash Growth
-46.37%-
Other Current Assets
1.040.88
Total Current Assets
18.4633.35
Property, Plant & Equipment
3.573.63
Long-Term Investments
0.080.08
Total Long-Term Assets
3.653.71
Total Assets
22.137.06
Accounts Payable
0.612.33
Other Current Liabilities
2.053.82
Total Current Liabilities
2.666.15
Long-Term Debt
00.05
Other Long-Term Liabilities
0.080.1
Total Long-Term Liabilities
0.080.14
Total Liabilities
2.746.29
Total Debt
00.05
Common Stock
8.177.27
Retained Earnings
-116.89-94.68
Shareholders' Equity
-108.71-87.41
Total Liabilities and Equity
-105.97-81.11
Net Cash / Debt
17.4132.42
Net Cash / Debt Growth
-46.29%-
Net Cash Per Share
3.466.99
Working Capital
15.7927.2
Book Value Per Share
-21.61-18.86
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).